Showing results (711-720 of 895) with videos related to

Sort By:
Pageof 90
Drugs in R&D|December 13, 2016
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch StudyFrank R Ernst, Walter Sandulli, Riad Elmor, et al.
Drugs in R&D|January 12, 2017
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification SystemNasir Idkaidek, Tawfiq Arafat, Hazim Hamadi, et al.
Drugs in R&D|January 12, 2017
Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case ReportAtsushi Tanaka, Tsukasa Nakamura, Eiichi Sato, et al.
Drugs in R&D|January 13, 2017
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in NeonatesChristine M Sanfilippo, Catherine M Allaire, Heleen H DeCory
Drugs in R&D|January 13, 2017
Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation ModelSteven M Brunelli, Scott P Sibbel, David Van Wyck, et al.
Drugs in R&D|December 1, 2021
Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover StudyPing Shi, Xin Liu, Ting Li, et al.
Drugs in R&D|December 28, 2021
Pharmacokinetics and Pharmacodynamics of IbrexafungerpMatthew William McCarthy
Drugs in R&D|July 25, 2016
Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled TrialsSamantha Forder, Michael Voelker, Angel Lanas
Drugs in R&D|August 5, 2021
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized StudyPeter Hanson, Alan Kivitz, Purvi Mehra, et al.
Drugs in R&D|August 20, 2022
Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control StudyMaki Umemiya, Yoshihide Inayama, Eiji Nakatani, et al.
Pageof 90